Alopecia in Patients Treated with Molecularly Targeted Anticancer Therapies
September 2015
in “
Annals of Oncology
”
Studysummary This study reported that targeted anticancer therapies are associated with an increased risk of alopecia compared to placebo, although the risk was lower compared to chemotherapy.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on annalsofoncology.org →